We demonstrated that miR-137 was downregulated in GBM due to promoter hypermethylation and that miR-137 inhibited GSC self-renewal and promoted the differentiation of these cells by targeting RTVP-1 which downregulated CXCR4 [18]. This evidence concerns the gene GLIPR1 and glioblastoma.